Global Cardiac Rhythm Management (CRM) Devices Market Insights, Forecast to 2025

Cardiac Rhythm Management Device is a medical device which uses electrical impulses, delivered by electrodes contracting the heart muscles, to regulate the beating of the heart.

A cardiac rhythm management device (CRMD) refers to any permanently implanted cardiac pacemaker or any implantable cardioverter-defibrillator (ICD). The term CRMD also refers to any cardiac resynchronization device. The term CRT refers to a CRMD that provides cardiac resynchronization therapy using biventricular pacing techniques.

Increasing instances of heart failure and other cardiac disorders and rising sedentary lifestyle among the population are estimated to boost market growth through 2025.

The classification of Cardiac Rhythm Management Device includes Pacemakers, ICD and CRT. And the proportion of Pacemakers in 2017 is about 49.1%. The ICD in 2017 is about 36.6%.

Cardiac Rhythm Management Device is widely used in Bradycardia, Tachycardia, heart failure and other. Tachycardia and bradycardia are the most common indications for treatment, heart failure, diabetes and obesity can contribute to ongoing rhythm management concerns. And the market share used tachycardia in 2017 is 42.8%. And the market share used bradycardia in 2018 is 39.9%.

North America region is the largest supplier of Cardiac Rhythm Management Device, with a production market share nearly 84.7% in 2017. Europe is the second largest supplier of Cardiac Rhythm Management Device Media, enjoying production market share nearly 12.4% in 2017.

North America is the largest consumption place, with a consumption market share nearly 51.5% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 28.3%, Cardiac Rhythm Management Device market in Asia Pacific region is expected to exhibit the highest growth rate especially in the developing Asian countries like China & India.

Market competition is intense among top 5. Medtronic, St. Jude Medical (Abbott), Boston Scientific, Biotronik, LivaNova (Sorin) are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

The global Cardiac Rhythm Management (CRM) Devices market is valued at 10200 million US$ in 2018 and will reach 14500 million US$ by the end of 2025, growing at a CAGR of 4.5% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Cardiac Rhythm Management (CRM) Devices market based on company, product type, end user and key regions.

This report studies the global market size of Cardiac Rhythm Management (CRM) Devices in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Cardiac Rhythm Management (CRM) Devices in these regions.
This research report categorizes the global Cardiac Rhythm Management (CRM) Devices market by top players/brands, region, type and end user. This report also studies the global Cardiac Rhythm Management (CRM) Devices market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Medtronic
St. Jude Medical (Abbott)
Boston Scientific
Biotronik
LivaNova (Sorin)
Medico
Lepu (Qinming Medical)
IMZ
Cardioelectronica
Pacetronix

Market size by Product
Pacemaker
ICD
CRT
Market size by End User
Bradycardia
Tachycardia
Heart Failure
Other

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Cardiac Rhythm Management (CRM) Devices market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Cardiac Rhythm Management (CRM) Devices market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Cardiac Rhythm Management (CRM) Devices companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Cardiac Rhythm Management (CRM) Devices submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Cardiac Rhythm Management (CRM) Devices are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Cardiac Rhythm Management (CRM) Devices market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Frequently Asked Questions